Cargando…
In silico repositioning of approved drugs against Schistosoma mansoni energy metabolism targets
Schistosomiasis is a neglected parasitosis caused by Schistosoma spp. Praziquantel is used for the chemoprophylaxis and treatment of this disease. Although this monotherapy is effective, the risk of resistance and its low efficiency against immature worms compromises its effectiveness. Therefore, it...
Autores principales: | Calixto, Nicole Melo, dos Santos, Daniela Braz, Bezerra, José Clecildo Barreto, Silva, Lourival de Almeida |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6312253/ https://www.ncbi.nlm.nih.gov/pubmed/30596650 http://dx.doi.org/10.1371/journal.pone.0203340 |
Ejemplares similares
-
In Silico Repositioning-Chemogenomics Strategy Identifies New Drugs with Potential Activity against Multiple Life Stages of Schistosoma mansoni
por: Neves, Bruno J., et al.
Publicado: (2015) -
Repositioning of new potential schistosomicidal drugs using chemogenomic strategy
por: Duarte, Arthur Scalzitti, et al.
Publicado: (2014) -
In Silico Search of Energy Metabolism Inhibitors for Alternative Leishmaniasis Treatments
por: Silva, Lourival A., et al.
Publicado: (2015) -
Activity Profile of an FDA-Approved Compound Library against Schistosoma mansoni
por: Panic, Gordana, et al.
Publicado: (2015) -
Correction: In Silico Repositioning-Chemogenomics Strategy Identifies New Drugs with Potential Activity against Multiple Life Stages of Schistosoma mansoni
Publicado: (2015)